首页>
外文期刊>European Journal of Cancer Supplements
>Colloidal immunochemogene formulation SEVINA-VI composed of anti-MUC1 MAbs, clamp PNA against mRNA of elF3c, and vinorelbine in stealth liposomes induce PCD in HRBC resistant to trastuzumab, cetuximab, and taxanes
【24h】
Colloidal immunochemogene formulation SEVINA-VI composed of anti-MUC1 MAbs, clamp PNA against mRNA of elF3c, and vinorelbine in stealth liposomes induce PCD in HRBC resistant to trastuzumab, cetuximab, and taxanes